Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

May 17, 2025
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • HOW CANCER CELLS TO ESCAPE THE IMMUNE SYSTEM?

ICAR-NBPGR Genomics Recruitment | Applications Invited

Dr. Ambedkar Centre for Biomedical Research JRF | Biotech & Life Science Apply

HOW CANCER CELLS TO ESCAPE THE IMMUNE SYSTEM?
  • BiotechToday
  • World

HOW CANCER CELLS TO ESCAPE THE IMMUNE SYSTEM?

bioxone January 9, 2021January 9, 2021

PRAGYA SANTRA, AMITY UNIVERSITY KOLKATA

The history of cancer research has always been a mystery in the result. Recently it was reported that cancer cells adapted themselves to grow and proliferate in an inflammatory environment. ENPP1, a readily accessible molecule found on the surface of cancer cells plays a major role in this mechanism. 

Naturally, free-floating DNA in the cytosol of the cancer cells triggers a red alert signifying the presence of unstable chromosomes. This cautious signal further activates a particular immunity pathway called the cGAS-STING pathway. cGAS binds to the chromosome and activates the immune response called STING which causes inflammation. Many cGAMP complexes also alert the neighboring immune cells in response to cancer. It has been noticed that in spite of self-destruction signals the cancer cells survived and thrive well in the unfavorable environment too. 

In a new study, the reason for such an exception is reported. The scientists could figure out the reason which permits the cancer cells to sustain even in an unsuitable environment. A new molecule is being found which destroys the warning signals before it reaches the immune cells for activation. Due to this reason, certain cancers do not respond to immunotherapeutic drugs. 

The current research highlights that the cancer cells counter the warning signals that activate the cGAS-STING complexes. ENPP1, a scissor-like protein coating the outer surface of the cancer cells foils the immune triggering signals, suppressing the innate immune response. When cGAMP departs the cell to reach its destination for triggering the neighboring immune cells ENPP1 digests it, hindering its function. Besides an immune-suppressing molecule, adenosine is also released which subdues the inflammation. Scientists observed that switching on ENPP1 suppresses the immune system and enhances metastasis.

The scientists are now in the process to develop drugs that can inhibit the ENPP1 on the cancer cells; which further can block the metastasis to some extent and support the immunotherapy. Simultaneously research is also in progress to prevent the over-production of immune-suppressive adenosine.

Also read:Climate Change and Animal Appearances: Renewed discussions on Gloger’s rule

Source: Metastasis and immune evasion from extracellular cGAMP hydrolysis; Jun Li, Mercedes A Duran et al.; American Association for Cancer Research; 2020-2021; doi: https://doi.org/10.1158/2159-8290.CD-20-0387 

  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP
  • AI Literacy in Early Childhood Education: Challenges and Opportunities

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X

Related

Tagged adenosine cancer cGAS-STING pathway ENPP1 immune system Immunotherapy inflammations metastasis signals

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • Job and Internship
  • Signaling Pathway

Dr. Ambedkar Centre for Biomedical Research JRF | Biotech & Life Science Apply

bioxone January 9, 2021

-Shristi Sharma, Team bioXone ACBR Jobs For Lifescience & Biotech – JRF Job. MSc Life Science / Biotechnology & MTech Biotechnology candidates are encouraged to apply for Junior Research Fellow jobs at the University of Delhi. Research vacancies at Delhi University. Check out all of the details below: Dr. B.R. Ambedkar Centre for Biomedical Research […]

Related Post

  • BiotechToday
  • World

PARP inhibitors: One class of drugs for Multiple Forms of Cancer

bioxone June 10, 2021June 10, 2021

Sayak Banerjee, Amity University Kolkata Scientists have come over a class of drugs utilized in the treatment of breast and ovarian cancer which might be effective in other types of diseases with inadequate treatment alternatives. These are called PARP inhibitors which have the potential to kill cancer cells carrying a defect in the Polybromo 1(PBRM1) […]

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X
  • BiotechToday
  • World

Poor man’s diet, millets can lower the risk of diabetes

BioTech Today July 31, 2021July 31, 2021

Parnad Basu, Amity University Kolkata Diabetes mellitus type 2: It is the most common type of diabetes that happens to middle-aged or older people though kids suffering from childhood obesity are also at risk. In case of the type 2 diabetes, insulin (a hormone created in the pancreas) doesn’t get used by our cells, which […]

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X
  • BiotechToday
  • World

The Myth of ‘COVID-19 Curve Flattening’

bioxone November 3, 2020November 2, 2020

Chitra Roy, University of Calcutta Several months into the pandemic and the coronavirus is not only reaching into remote areas but also to regions that had previously been battered by the virus. This has led to a recent rise in the number of cases in the U.S. The last seven-day average for new cases is […]

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy